Antacids Market Share And Industry Trends, Forecasts Till, 2014 - 2025
Besides, growth in e-Commerce is expected to drive demand for antacids via online retailing channels in the subsequent years. In other words, growing popularity on the part of e-Commerce coupled with an increase in online medicine providers is expected to bolster the market. At the same time, restraints do exist in the form of intake by young children. “Gut” journal states that young children displayed obesity symptoms on intake of antacids. As far as infants are concerned, antacids are a strict “no-no”. Even during pregnancy antacids should be avoided as chances of pre-mature birth can’t be ruled out.
Download Free Sample - https://www.millioninsights.com/industry-reports/antacids-market/request-sample
The antacids market is segmented based on drug class, type of formulation, distribution channel, and geography. By drug class, the segmentation spans proton pump inhibitors, and H2 antagonists (interventional/surgical simulators), and acid neutralizers. By type of formulation, the antacids industry comprises tablet, liquid, and powder. By distribution channel, it consists of retail pharmacies, hospital pharmacies, and other distribution channels. By geography, the antacid market is segmented into North America, LATAM, Asia Pacific, Europe, and MEA.
The players contributing to the antacids market include Bayer AG, AstraZeneca PLC, Sanofi S.A., Reckitt Benckiser Group PLC, Procter & Gamble, Pfizer Inc., Johnson & Johnson, and Dr. Reddy’s Laboratories Ltd.
Comments
Post a Comment